Market Overview
Vascular access devices are essential medical instruments that enable healthcare providers to deliver therapies, withdraw blood, and monitor patients through the circulatory system. The market spans a wide range of products from basic peripheral IV catheters to advanced central venous access systems, with the overall market valued at $3.09 billion in 2025 and expected to maintain steady expansion through 2035. Product development is heavily influenced by clinical evidence requirements and regulatory oversight from agencies including the FDA.
- •The central venous catheter segment is projected to grow at a 6.6% CAGR from 2025 through 2035
- •Midline catheters represent one of the fastest-growing sub-segments, approaching $265 million by 2030 with a CAGR exceeding 5%
- •Broader intravenous medical device markets globally are experiencing growth around 8% CAGR through 2030
Growth Drivers
The rising global burden of chronic conditions such as cancer, diabetes, and end-stage renal disease is creating sustained demand for reliable vascular access solutions. An aging population and increasing hospital admission rates, particularly for surgical patients requiring intravenous therapy, are expanding the patient pool needing these devices. Additionally, the shift toward outpatient and home-based care is driving demand for devices that are easier to insert, more secure, and associated with fewer complications.
- •Chronic disease prevalence and aging demographics are increasing long-term intravenous therapy needs
- •Growing procedural volumes in interventional medicine, including electrophysiology, are expanding specialized access requirements
- •Clinical evidence highlighting infection prevention and patient safety benefits is accelerating adoption of advanced catheter technologies
Segmentation and Regional Analysis
The market is segmented by product type, including peripheral intravenous catheters, central venous catheters, midline catheters, peripherally inserted central catheters, and vascular closure devices. Regional dynamics vary significantly, with North America and Europe representing mature markets characterized by advanced healthcare infrastructure and stringent regulatory requirements, while Asia-Pacific and emerging markets are expanding rapidly due to improving healthcare access and rising procedural volumes. The broader global regulatory environment is evolving as agencies work to harmonize standards across jurisdictions.
- •Midline catheters and central venous catheters are key growth segments within the overall market
- •Real-world hospital data demonstrates substantial utilization of peripheral IV catheters in surgical patient populations
- •International regulatory harmonization efforts are influencing product development and market entry strategies globally
Trends and Outlook
What are the recent trends and outlook?
Emerging technologies such as near-infrared light devices for vein visualization are improving first-stick success rates and reducing patient discomfort during peripheral access procedures. Integrated securement devices are gaining favor over traditional suture methods due to reduced infection risk and improved catheter stability. Over the coming decade, the market is expected to benefit from continued procedural volume growth, ongoing product innovation focused on safety and usability, and expanding indications for vascular access across new clinical settings.
- •Near-infrared vein visualization technology is gaining adoption to improve peripheral IV insertion success
- •Integrated securement solutions are replacing sutures to reduce complications and improve catheter longevity
- •Ongoing research into microplastics from medical devices is influencing material selection and regulatory scrutiny
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.